by Max Wallace
Guest blogger Max Wallace is the CEO of Accelerate Brain Cancer Cure (ABC2), a Case Foundation partner organization.
Last Tuesday, the ABC2 team attended a hearing of the FDA’s Oncologic Drug Advisory Committee in Silver Spring, MD. The Committee...
